{"id":4476,"date":"2020-12-04T11:04:21","date_gmt":"2020-12-04T11:04:21","guid":{"rendered":"http:\/\/www.scottishmesotheliomanetwork.scot.nhs.uk\/?page_id=4476"},"modified":"2024-02-12T16:49:00","modified_gmt":"2024-02-12T16:49:00","slug":"meso-matters-webinars","status":"publish","type":"page","link":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/news-and-events\/events\/meso-matters-webinars\/","title":{"rendered":"2020 Meso Matters Webinars"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">30 November 2020 \u2013 Nanotubes, Gold and Mesothelioma\u00a0<\/h2>\n\n\n\n<p>An insight into a breakthrough study which looks at the potential of gold nanotubes \u2013 tiny hollow cylinders one thousandth of the width of a human hair \u2013 to be placed inside cancer cells, causing them to heat up and thereby kill the mesothelioma cells.<\/p>\n\n\n\n<p>Experts: Stefan Marciniak, Professor of Respiratory Science Cambridge, Honorary Consultant Respiratory Physician at Addenbrookes and Papworth and Stephen Evans, Professor of Molecular and Nanoscale Physics.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mesothelioma Matters November Webinar - Nanotubes, Gold and Mesothelioma\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/ktPGYcDee1E?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">25 January 2021 \u2013 Mesothelioma Surgery in the UK post MARS2 recruitment<\/h2>\n\n\n\n<p>Expert: Dr John Edwards, Consultant Thoracic Surgeon with major interest in mesothelioma research<\/p>\n\n\n\n<p>The latest Mesothelioma Matters webinar, John Edwards, Consultant Thoracic Surgeon from Sheffield Teaching Hospitals, discusses Extended Pleurectomy Decortication (EPD), what the procedure is, why it became the focus of such a large-scale clinical trial, why evidence to support the procedure or not is necessary, and if or how EPD can be accessed, whilst MARS 2 results become available.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mesothelioma Matters Webinar January 2021: Mesothelioma Surgery in the UK post MARS2 recruitment\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/9qglOvUr1mc?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">22 February 2021 \u2013 Establishing a Mesothelioma MDT<\/h2>\n\n\n\n<p>Multidisciplinary Team Working in cancer care is well established and appreciated in the UK.&nbsp; Achieving this in &nbsp;rarer cancers, like mesothelioma is challenging, but given the widespread benefits of ensuring patients receive a specialist review and opinion, it is essential we overcome these challenges, if we are going to we provide an equitable optimal service for anyone affected by rarer cancers.<\/p>\n\n\n\n<p>Experts: Dr Paul Beckett, Respiratory Physician Clinical Lead for National Lung Cancer Audit and Professor Kevin Blyth, Professor of Respiratory Medicine \u2013 University of Glasgow and Pleural Diseases Lead at Queen Elizabeth University Hospital Glasgow.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mesothelioma Matters Webinar 3\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/6iu3wmqX944?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">29 March 2021 \u2013\u00a0 Chemo-Immunotherapy<\/h2>\n\n\n\n<p>Clinical trials will hopefully soon become available that use chemotherapy and immunotherapy at the same time. This presentation explored the pre-clinical and emerging clinical data on chemo-immunotherapy, the potential of predictive biomarkers of response, and where chemo-immunotherapy clinical trials should be considered in the management algorithm for mesothelioma.<\/p>\n\n\n\n<p>Experts: Professor Anna Nowak, Medical Oncologist from Perth, Australia<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mesothelioma Matters Webinar 4\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/svQOwwfrKEM?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">26 April 2021 \u2013 The UK Peritoneal Mesothelioma MDT<\/h2>\n\n\n\n<p>Faheez Mohammed Consultant Colorectal Surgeon and Samantha Westbrook Peritoneal Mesothelioma Clinical Nurse Specialist present their experience of managing peritoneal mesothelioma including diagnosis, treatment with Cytoreductive Surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), the National Peritoneal MDT and the role of our the Peritoneal Specialist Nurse<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"The UK Peritoneal Mesothelioma MDT\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/LCIzftIsl_0?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">24 May 2021 \u2013 Mesothelioma Heterogeneity\u00a0<\/h2>\n\n\n\n<p>Experts: Didier Jean, Senior Research Scientist at French National Institute of Health &amp; Medical Research with particular interest in research into mesothelioma.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mesothelioma Matters Webinar 6 - Heterogeneity in Mesothelioma\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/jEshyHHSb20?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">28 June 2021 \u2013 Mesothelioma UK Research Centre \u00a0<\/h2>\n\n\n\n<p>Experts: The team from the Mesothelioma UK Research Centre talk about its Research Prioritisation Exercise which aims to identify areas of research which are a priority for patients and carers.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mesothelioma Matters Webinar 7  - Mesothelioma UK Research Centre\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/a5WdhpoNRwQ?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">26 July 2021 \u2013 Mesothelioma UK Projects<\/h2>\n\n\n\n<p>This webinar introduces three Mesothelioma UK projects: 1) Meso-DAX \u2013 a new digital data collection service providing patients with ongoing feedback and support, 2) Asbestos Smart \u2013 an easy to use technological solution which gives contractors and on-site personnel immediate access to the latest asbestos register for buildings, and 3) the new Mesothelioma UK Clinical Trials App.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Mesothelioma Matters Webinar 8 - Mesothelioma UK Projects\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/I9VJ8d6GoVc?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">24 August 2021 \u2013\u00a0Combination Immunotherapy in\u00a0Mesothelioma<\/h2>\n\n\n\n<p>Expert: Dr Paul Baas, Chief of the department of Thoracic Oncology at the Netherlands Cancer Institute in Amsterdam talks about the implementation of immunotherapy treatment in both lung cancer and mesothelioma.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-rich is-provider-embed-handler wp-block-embed-embed-handler\"><div class=\"wp-block-embed__wrapper\">\nhttps:\/\/youtube.com\/watch?v=gJmvS7KkPc4%3Ffeature%3Doembed\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">27 September 2021 \u2013 Mesothelioma PhD Scholars Showcase<\/h2>\n\n\n\n<p>Expert: PhD students share their mesothelioma research<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Meso UK webinar #10-v2\" src=\"https:\/\/player.vimeo.com\/video\/620017957?dnt=1&amp;app_id=122963\" width=\"640\" height=\"360\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture; clipboard-write\"><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p class=\"nhsuk-card__description\">30 November 2020 \u2013 Nanotubes, Gold and Mesothelioma\u00a0 An insight into a breakthrough study which looks at the potential of [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":3315,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4476","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/4476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/comments?post=4476"}],"version-history":[{"count":41,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/4476\/revisions"}],"predecessor-version":[{"id":6311,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/4476\/revisions\/6311"}],"up":[{"embeddable":true,"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/pages\/3315"}],"wp:attachment":[{"href":"https:\/\/www.nn.nhs.scot\/scottishmesotheliomanetwork\/wp-json\/wp\/v2\/media?parent=4476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}